rs3138808
Positions:
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-A
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACAC
- chr7-151002383-AACACACACACACACACACACACACACACACACACACACACACACAC-AACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACACAC
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000603.5(NOS3):c.1752+104_1752+149del variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000111 in 271,084 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000015 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0000097 ( 0 hom. )
Consequence
NOS3
NM_000603.5 intron
NM_000603.5 intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.908
Genes affected
NOS3 (HGNC:7876): (nitric oxide synthase 3) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NOS3 | NM_000603.5 | c.1752+104_1752+149del | intron_variant | ENST00000297494.8 | NP_000594.2 | |||
NOS3 | NM_001160109.2 | c.1752+104_1752+149del | intron_variant | NP_001153581.1 | ||||
NOS3 | NM_001160110.1 | c.1752+104_1752+149del | intron_variant | NP_001153582.1 | ||||
NOS3 | NM_001160111.1 | c.1752+104_1752+149del | intron_variant | NP_001153583.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NOS3 | ENST00000297494.8 | c.1752+104_1752+149del | intron_variant | 1 | NM_000603.5 | ENSP00000297494 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000153 AC: 1AN: 65212Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
1
AN:
65212
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000972 AC: 2AN: 205814Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 113944
GnomAD4 exome
AF:
AC:
2
AN:
205814
Hom.:
AF XY:
AC XY:
0
AN XY:
113944
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000153 AC: 1AN: 65270Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 30074
GnomAD4 genome
AF:
AC:
1
AN:
65270
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
30074
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at